SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Tularik Inc. (TLRK)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who started this subject8/13/2002 8:11:50 AM
From: Doc Bones  Read Replies (1) of 598
 
07:47 ET TLRK Tularik downgraded by B of A (8.79)
Banc of America downgrades to MKT PERFORM from Buy; believes Aug 26 FDA meeting on the development plan for T-67 adds risk without commensurate reward; sees odds of an FDA endorsement of the T-67 Phase III trial at just 60-40.

[Briefing.com]

TLRK trading at 8.25 in pre-market, 8:10 EST
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News